SHE:300122 Market Cap

SHE:300122 has a market cap or net worth of 35.74 billion as of April 28, 2026. Its market cap has decreased by -38.48% in one year.

Market Cap

35.74B

Enterprise Value

45.60B

Revenue

8.75B

Ranking

n/a

PE Ratio

n/a

Stock Price

15.05

Market Cap Chart

Since September 28, 2010, SHE:300122's market cap has increased from 15.42B to 35.74B, an increase of 131.77%. That is a compound annual growth rate of 5.54%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	35.74B	-20.88%
Dec 31, 2025	45.17B	-28.25%
Dec 31, 2024	62.96B	-57.07%
Dec 29, 2023	146.66B	4.37%
Dec 30, 2022	140.53B	-29.51%
Dec 31, 2021	199.36B	-15.76%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shanghai RAAS Blood Products	35.87B
Hebei Changshan Biochemical Pharmaceutical	36.39B
Shanghai Allist Pharmaceuticals	41.03B
Asymchem Laboratories (Tianjin)	41.62B
Beijing Tiantan Biological Products	28.63B
Sunshine Guojian Pharmaceutical (Shanghai)	47.13B
Suzhou Zelgen Biopharmaceuticals	26.47B
Hualan Biological Engineering	26.43B

Market Cap Rankings